Feinsod Matthew 4
4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Jul 31, 2019
Insider Transaction Report
Form 4
Feinsod Matthew
Interim Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2019-07-29+100,000→ 100,000 totalExercise: $3.91Exp: 2029-07-29→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Option becomes exercisable based on the achievement of certain performance milestones. For each milestone met, the option vests as to 16,666.6667 shares of the Company's common stock in accordance with the following schedule: 25% of the underlying shares for such milestone vest on achievement of such milestone, and thereafter the remaining underlying shares for such milestone vest in equal monthly installments over three years, resulting in the option being exercisable for 100% of the underlying shares for such milestone on the third anniversary of the achievement of the applicable milestone.